Omega Healthcare Investors reported third quarter 2026 net income of $87 million and adjusted funds from operations of $262 million, or $0.82 per diluted share. The company raised its full-year 2026 Adjusted FFO guidance range to $3.28 to $3.30 per diluted share and declared a quarterly cash dividend of $0.68 per share.
Net income for the third quarter of 2026 was $87 million, or $0.27 per diluted share.
Adjusted Funds From Operations reached $262 million, or $0.82 per diluted share, compared to $243 million, or $0.79 per diluted share, in Q3 2025.
The company completed $1.5 billion in total new investments year-to-date, including $946 million since quarter-end.
Full-year 2026 Adjusted FFO guidance was raised to a range of $3.28 to $3.30 per diluted share.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Omega Healthcare Investors's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$1.19B
+13.2%
$1.94
+25.2%
49.6%
FY2024
$1.05B
+10.7%
$1.55
+55.0%
38.6%
FY2023
$949.74M
+8.1%
$1.00
-44.4%
25.5%
FY2022
$878.24M
-17.4%
$1.80
+2.9%
48.6%
FY2021
$1.06B
+19.1%
$1.75
+150.0%
39.2%
Frequently asked questions
When is Omega Healthcare Investors's next earnings date?
Omega Healthcare Investors has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Omega Healthcare Investors earn last quarter?
For the quarter ended Sep 2026, Omega Healthcare Investors reported diluted EPS of $0.27 (-54.2% year over year) on revenue of $30.76M (-90.1%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.